Vercide, Danica Joy .
HRN: 27-87-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFUROXIME 500MG (TAB)
09/28/2025
10/05/2025
PO
500 Mg
BID
S/P NSVD, Postpartum Hemorrhage (referral)
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes